MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas

RNA

Volumn 19, Issue 4, 2013, Pages 552-560

  Shi, Zhu Mei ^a   Wang, Xie Feng ^a   Qian, Xu ^a   Tao, Tao ^a   Wang, Lin ^a   Chen, Qiu Dan ^a   Wang, Xi Rui ^b   Cao, Lei ^c   Wang, Ying Yi ^a   Zhang, Jun Xia ^a   Jiang, Tao ^d   Kang, Chun Sheng ^e   Jiang, Bing Hua ^a   Liu, Ning ^a   You, Yong Ping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b CANGZHOU CENTRAL HOSPITAL   (China)

^c MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Carcinogenesis; Glioma; IGF 1R; miR 181b

Indexed keywords

MICRORNA; MIRNA 181B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR SUPPRESSOR GENE;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 84875420749     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.035972.112     Document Type: Article

References (26)

1. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Baserga R, Peruzzi F, Reiss K. 2003. The IGF-1 receptor in cancer biology. Int J Cancer 107: 873-877.
3. Cao Z, Liu LZ, Dixon DA, Zheng JZ, Chandran B, Jiang BH. 2007. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells. Cell Signal 19: 1542-1553.
4. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
5. De Luca A, Maiello MR, D'Alessio A, Pergameno M, Normanno N. 2012. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: Role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets 16 (Suppl 2): S17-S27.
6. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs - microRNAs with a role in cancer. Nat Rev 6: 259-269.
7. Fang J, Xia C, Cao Z, Zheng JZ, Reed E, Jiang BH. 2005. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/ p53 pathways. FASEB J 19: 342-353.
8. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, Lawler S. 2008.Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-9130.
9. Jia CY, Li HH, Zhu XC, Dong YW, Fu D, Zhao QL, Wu W, Wu XZ. 2011. MiR-223 suppresses cell proliferation by targeting IGF-1R. PloS ONE 6: e27008.
10. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, et al. 2008. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68: 3566-3572.
11. Kong KL, Kwong DL, Chan TH, Law SY, Chen L, Li Y, Qin YR, Guan XY. 2012. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin- like growth factor 1 receptor. Gut 61: 33-42.
12. Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, Jeong JA, Jo SH, Kim TH, Min HS, Chae JS, et al. 2011. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30: 2433-2442.
13. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115: 787-798.
14. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
15. Liu LZ, Zheng JZ, Wang XR, Jiang BH. 2008. Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis. Cancer Res 68: 8183-8188.
16. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔC(T) method. Methods 25: 402-408.
17. Pollak M. 2008. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev 8: 915-928.
18. Sana J, Hajduch M, Michalek J, Vyzula R, Slaby O. 2011. MicroRNAs and glioblastoma: Roles in core signalling pathways and potential clinical implications. J Cell Mol Med 15: 1636-1644.
19. ShiB,Sepp-LorenzinoL, PriscoM,LinsleyP,deAngelisT,BasergaR.2007. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 282: 32582-32590.
20. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, You Y. 2008. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236: 185-193.
21. Sun X, Icli B, Wara AK, Belkin N, He S, Kobzik L, Hunninghake GM, Vera MP, Blackwell TS, Baron RM, et al. 2012. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest 122: 1973-1990.
22. Tognon CE, Sorensen PH. 2012. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opin Ther Targets 16: 33-48.
23. Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS. 2009. Experience with irinotecan for the treatment of malignant glioma. Neuro Oncol 11: 80-91.
24. Wang X. 2009. A PCR-based platform for microRNA expression profiling studies. RNA 15: 716-723.
25. Xia H, Cheung WK, Ng SS, Jiang X, Jiang S, Sze J, Leung GK, Lu G, Chan DT, Bian XW, et al. 2012. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem 287: 9962-9971.
26. Zhao X, Dou W, He L, Liang S, Tie J, Liu C, Li T, Lu Y, Mo P, Shi Y, et al. 2012. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene doi: 10.1038/onc.2012.156.